Eximis Surgical Secures $7.5 Million in Financing

LOUISVILLE, Colo., Nov. 8, 2018 /PRNewswire/ — Eximis Surgical, Inc. today announced it has secured $7.5 million in financing led by Questa Capital, with participation from Venture Investors. Eximis Surgical is developing a transformational surgical platform for the removal of large specimens through small laparoscopic incisions. The Eximis...
Read More →

Eximis Surgical: Filling a Gap in Laparoscopic Tissue Removal

The notorious morcellator, a tool for the laparoscopic removal of uterine fibroids and other tissues, has largely gone into disuse since the FDA issued a black box warning about the devices because of their potential for spreading cancerous cells. Eximis Surgical is filling the gap with a laparoscopic device that it says will not only be safe, but will also offer procedural advantages and result in higher quality tissue specimens for analysis.